These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 17654443)

  • 21. Endothelial progenitor cells in vascular health: focus on lifestyle.
    Van Craenenbroeck EM; Conraads VM
    Microvasc Res; 2010 May; 79(3):184-92. PubMed ID: 20053364
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel hypothesis of atherosclerosis: EPCs-mediated repair-to-injury.
    Zhang M; Zhou SH; Li XP; Shen XQ; Fang ZF
    Med Hypotheses; 2008; 70(4):838-41. PubMed ID: 17920780
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationships between vascular dysfunction, circulating endothelial progenitor cells, and psychological status in healthy subjects.
    Chen H; Yiu KH; Tse HF
    Depress Anxiety; 2011 Aug; 28(8):719-27. PubMed ID: 21681866
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair.
    Schmidt-Lucke C; Rössig L; Fichtlscherer S; Vasa M; Britten M; Kämper U; Dimmeler S; Zeiher AM
    Circulation; 2005 Jun; 111(22):2981-7. PubMed ID: 15927972
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potential role of endothelial progenitor cells in the pathophysiology of heart failure: clinical implications and perspectives.
    Andreou I; Tousoulis D; Tentolouris C; Antoniades C; Stefanadis C
    Atherosclerosis; 2006 Dec; 189(2):247-54. PubMed ID: 16860805
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Challenges in vascular repair by endothelial progenitor cells in diabetic patients.
    António N; Fernandes R; Ribeiro CF; Providência LA
    Cardiovasc Hematol Disord Drug Targets; 2010 Sep; 10(3):161-6. PubMed ID: 20678063
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The endothelium and vascular inflammation in diabetes.
    Hartge MM; Unger T; Kintscher U
    Diab Vasc Dis Res; 2007 Jun; 4(2):84-8. PubMed ID: 17654441
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The peroxisome proliferator-activated receptor-gamma agonist pioglitazone increases number and function of endothelial progenitor cells in patients with coronary artery disease and normal glucose tolerance.
    Werner C; Kamani CH; Gensch C; Böhm M; Laufs U
    Diabetes; 2007 Oct; 56(10):2609-15. PubMed ID: 17623816
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The link between microalbuminuria, endothelial dysfunction and cardiovascular disease in diabetes.
    Naidoo DP
    Cardiovasc J S Afr; 2002; 13(4):194-9. PubMed ID: 12389063
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The pleiotropic effects of ARB in vascular endothelial progenitor cells.
    Matsuura K; Hagiwara N
    Curr Vasc Pharmacol; 2011 Mar; 9(2):153-7. PubMed ID: 21143169
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic regulation of endothelial dysfunction in type 2 diabetes mellitus.
    Hamilton SJ; Chew GT; Watts GF
    Diab Vasc Dis Res; 2007 Jun; 4(2):89-102. PubMed ID: 17654442
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of insulin resistance in the pathogenesis of atherosclerotic cardiovascular disease: an updated review.
    Reddy KJ; Singh M; Bangit JR; Batsell RR
    J Cardiovasc Med (Hagerstown); 2010 Sep; 11(9):633-47. PubMed ID: 20164784
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endothelial precursors in vascular repair.
    Kirton JP; Xu Q
    Microvasc Res; 2010 May; 79(3):193-9. PubMed ID: 20184904
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Level of serum IL-12 and its correlation with endothelial dysfunction, insulin resistance, proinflammatory cytokines and lipid profile in newly diagnosed type 2 diabetes.
    Mishra M; Kumar H; Bajpai S; Singh RK; Tripathi K
    Diabetes Res Clin Pract; 2011 Nov; 94(2):255-61. PubMed ID: 21855158
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endothelial progenitor cells as a new agent contributing to vascular repair.
    Miller-Kasprzak E; Jagodziński PP
    Arch Immunol Ther Exp (Warsz); 2007; 55(4):247-59. PubMed ID: 17659378
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insulin resistance and endothelial dysfunction: the road map to cardiovascular diseases.
    Cersosimo E; DeFronzo RA
    Diabetes Metab Res Rev; 2006; 22(6):423-36. PubMed ID: 16506274
    [TBL] [Abstract][Full Text] [Related]  

  • 37. AMPK activation as a strategy for reversing the endothelial lipotoxicity underlying the increased vascular risk associated with insulin resistance syndrome.
    McCarty MF
    Med Hypotheses; 2005; 64(6):1211-5. PubMed ID: 15823720
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Circulating endothelial progenitor cells in cardiovascular disorders.
    Geft D; Schwartzenberg S; George J
    Expert Rev Cardiovasc Ther; 2008 Sep; 6(8):1115-21. PubMed ID: 18793114
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Arterial endothelial cells: still the craftsmen of regenerated endothelium.
    Hagensen MK; Vanhoutte PM; Bentzon JF
    Cardiovasc Res; 2012 Aug; 95(3):281-9. PubMed ID: 22652005
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of progenitor endothelial cells in cardiovascular disease and upcoming therapies.
    Kawamoto A; Asahara T
    Catheter Cardiovasc Interv; 2007 Oct; 70(4):477-84. PubMed ID: 17894361
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.